ustekinumab-auub Wezlana

Selected indexed studies

• Mirikizumab (Omvoh) - an IL-23 antagonist for Crohn's disease. (Med Lett Drugs Ther, 2025) [PMID:40324965]
• Guselkumab (Tremfya) for ulcerative colitis. (Med Lett Drugs Ther, 2025) [PMID:40053377]
• In brief: Wezlana - an ustekinumab biosimilar interchangeable with Stelara. (Med Lett Drugs Ther, 2024) [PMID:39008107]

_Worker-drafted node — pending editorial review._